Developer docs
API playgroundTry for free, no card

Search company profiles

Bluestone Pharma

Full company profile

uuid000dcwg

Namestring
Bluestone Pharma
Legal namestring
Bluestone Pharma GmbH
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Bluestone Pharma GmbH is a Switzerland-based, privately held company that develops, manufactures, and distributes probiotic formulations specifically targeted at the oral microbiome. Founded in 2014 and headquartered in Baar, Switzerland, the company sells its products in more than 30 international markets, primarily through pharmacy channels, with local Health Care Practitioners functioning as the principal demand-generation mechanism. The company describes itself as first-to-market in pharmacy-distributed medical probiotics for oral health and as a category benchmark-setter for more than a decade.

The company's commercial offering is concentrated in a single brand, Bactoblis, which is sold as oral probiotic lozenges and sachets. Underlying technology centers on proprietary probiotic manufacturing processes designed to ensure stability, safety, and efficacy from raw ingredients through to finished product, with positioning anchored in clinical relevance to unmet patient needs in oral care. The company holds registered trademarks for both the BLUESTONE PHARMA corporate brand and the Bactoblis product brand, and it received the Nutra Ingredients Award 2025 in the Innovation / R&D category, signaling industry recognition of its formulation work.

Bluestone Pharma operates a sales-led, B2B/B2C hybrid model: products are sold through pharmacy retail while demand is shaped upstream by Health Care Practitioner recommendations. The company has a wholly-owned sales subsidiary, Bluestone Pharma Spain S.L., based in Sitges, to support European operations. No public pricing, revenue, funding history, cap table, or named enterprise customers are disclosed in the available data, and the business appears to be founder-held and self-funded.

Short descriptiontext

Bluestone Pharma GmbH is a Switzerland-based private company that develops and distributes the Bactoblis brand of oral probiotic lozenges and sachets through pharmacy channels in 30+ international markets, with demand driven by local Health Care Practitioner recommendations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBaar, Switzerland
HQ citystring
Baar
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oral microbiome probiotics, probiotic supplements, medical probiotics, probiotic manufacturing, pharmacy distribution
Industry2 codes
PRIMARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYAFAKAJAH
Probiotic, Prebiotic & Gut-Health Foods Manufacturing (Fermented Functional Foods, Synbiotics)
Agriculture & Food Production/Food Processing & Manufacturing/Specialty & Functional Foods Manufacturing (Organic, Fortified, Medical Foods)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Probiotic Supplements
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Probiotic Product Sales
TypeOne Time License
Description

Manufactures and sells innovative probiotic formulations (including Bactoblis brand products such as lozenges and sachets) through pharmacy channels across more than 30 international markets. Revenue generated through product sales with local Health Care Practitioners driving demand.

bluestone-pharma.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Bactoblis
Description

Probiotic product brand focused on oral microbiome health, marketed through the company's pharmacy channel.

bluestone-pharma.com
Core offering1 text field

Bluestone Pharma develops and manufactures innovative probiotic formulations focused on the oral microbiome, marketed under the Bactoblis brand as lozenges and sachets. Products are sold through pharmacy channels across more than 30 international markets, with local Health Care Practitioners driving demand and prescription behavior.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bluestone Pharma operates as an international operating company based in Switzerland developing and manufacturing innovative probiotic formulations focused on the oral microbiome, selling in more than 30 markets. Their product portfolio centers on Bactoblis, their core medical probiotic brand offering lozenges and sachets for oral microbiome support. For more than a decade, they have positioned themselves as pioneers in medical probiotics with pharmacy-first market entry, supported by local Healthcare Practitioners.

Product and service1 record
1Bactoblis
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Global bioscience company and major probiotic strain supplier to many CPG and supplement brands. Comparable as the upstream strain/probiotic ingredient ecosystem participant that both supplies and competes with downstream brands like Bluestone.

TypeEmerging player
Description

US-based direct-to-consumer and pharmacy probiotic brand featuring a PRO-Dental oral probiotic SKU. Comparable as a smaller, brand-led probiotic company operating in the oral microbiome space with similar product formats (lozenges/sachets).

3Lallemand Health Solutions
TypeOthers
Description

Canadian probiotic ingredient manufacturer with documented oral and gut health strains. Comparable as an enabling ecosystem participant supplying probiotic raw materials and finished formulations in the same category Bluestone serves.

TypeDirect peer
Description

New Zealand-based developer of BLIS K12 (Streptococcus salivarius K12), the foundational strain behind many oral probiotic products including Bactoblis. Closest direct competitor in the oral microbiome probiotic niche with overlapping strain technology and pharmacy-channel positioning.

TypeBroad incumbent
Description

Japanese global probiotics giant with deep pharmacy and healthcare channel presence in 40+ countries. Comparable as a large, established probiotics brand that defines category norms and competes for HCP endorsement and consumer shelf space.

6BioGaia
TypeDirect peer
Description

Swedish probiotics specialist with BioGaia Prodentis (L. reuteri) targeting oral health. Comparable as a clinically-substantiated, HCP-endorsed oral probiotic brand sold through pharmacy channels globally.

7BioGaia (Prodentis line)
TypeDirect peer
Description

Note: see BioGaia above. BioGaia Prodentis is the most directly competing oral-health probiotic line with shared clinical, pharmacy, and HCP-led distribution model.

8Culturelle (i-Health)
TypeBroad incumbent
Description

Mass-market probiotic brand owned by i-Health (Ferrosan/Chr. Hansen lineage). Comparable as a pharmacy-distributed probiotic consumer brand with adjacent oral/dental extensions (Culturelle Dental) competing for the same shelf.

9Winclove Probiotics
TypeDirect peer
Description

Dutch probiotic formulation company offering multi-strain oral microbiome products (e.g., Ecologic Oral). Comparable as a science-driven probiotics manufacturer selling finished formulations into healthcare/pharmacy channels.

TypeBroad incumbent
Description

Multinational food and dairy giant operating probiotic brands (Actimel, Activia) and adjacent supplement portfolios. Comparable as a deep-pocketed incumbent able to leverage scientific claims and global retail relationships to contest the oral probiotic niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bluestone Pharma

Probiotic Supplementsbluestone-pharma.com

Bluestone Pharma GmbH is a Switzerland-based private company that develops and distributes the Bactoblis brand of oral probiotic lozenges and sachets through pharmacy channels in 30+ international markets, with demand driven by local Health Care Practitioner recommendations.

What Bluestone Pharma does

Bluestone Pharma GmbH is a Switzerland-based, privately held company that develops, manufactures, and distributes probiotic formulations specifically targeted at the oral microbiome. Founded in 2014 and headquartered in Baar, Switzerland, the company sells its products in more than 30 international markets, primarily through pharmacy channels, with local Health Care Practitioners functioning as the principal demand-generation mechanism. The company describes itself as first-to-market in pharmacy-distributed medical probiotics for oral health and as a category benchmark-setter for more than a decade.

The company's commercial offering is concentrated in a single brand, Bactoblis, which is sold as oral probiotic lozenges and sachets. Underlying technology centers on proprietary probiotic manufacturing processes designed to ensure stability, safety, and efficacy from raw ingredients through to finished product, with positioning anchored in clinical relevance to unmet patient needs in oral care. The company holds registered trademarks for both the BLUESTONE PHARMA corporate brand and the Bactoblis product brand, and it received the Nutra Ingredients Award 2025 in the Innovation / R&D category, signaling industry recognition of its formulation work.

Bluestone Pharma operates a sales-led, B2B/B2C hybrid model: products are sold through pharmacy retail while demand is shaped upstream by Health Care Practitioner recommendations. The company has a wholly-owned sales subsidiary, Bluestone Pharma Spain S.L., based in Sitges, to support European operations. No public pricing, revenue, funding history, cap table, or named enterprise customers are disclosed in the available data, and the business appears to be founder-held and self-funded.

Bluestone Pharma firmographics

Firmographics
Name
Bluestone Pharma
Legal name
Bluestone Pharma GmbH
Website
https://bluestone-pharma.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Bluestone Pharma GmbH is a Switzerland-based private company that develops and distributes the Bactoblis brand of oral probiotic lozenges and sachets through pharmacy channels in 30+ international markets, with demand driven by local Health Care Practitioner recommendations.
Ownership category
akta.pro rank

Bluestone Pharma industry classification

Industry
Product category
Probiotic Supplements
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYAFAKAJAH
Probiotic, Prebiotic & Gut-Health Foods Manufacturing (Fermented Functional Foods, Synbiotics)
Agriculture & Food Production/Food Processing & Manufacturing/Specialty & Functional Foods Manufacturing (Organic, Fortified, Medical Foods)

Keywords

  • Oral microbiome probiotics
  • Probiotic supplements
  • Medical probiotics
  • Probiotic manufacturing
  • Pharmacy distribution

Where Bluestone Pharma is headquartered

Location

Headquarters

HQ city
Baar
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

Bluestone Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Probiotic Product Sales: Manufactures and sells innovative probiotic formulations (including Bactoblis brand products such as lozenges and sachets) through pharmacy channels across more than 30 international markets. Revenue generated through product sales with local Health Care Practitioners driving demand.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Bluestone Pharma product offering

Product offering

Core offering

Bluestone Pharma develops and manufactures innovative probiotic formulations focused on the oral microbiome, marketed under the Bactoblis brand as lozenges and sachets. Products are sold through pharmacy channels across more than 30 international markets, with local Health Care Practitioners driving demand and prescription behavior.

Product overview

Bluestone Pharma operates as an international operating company based in Switzerland developing and manufacturing innovative probiotic formulations focused on the oral microbiome, selling in more than 30 markets. Their product portfolio centers on Bactoblis, their core medical probiotic brand offering lozenges and sachets for oral microbiome support. For more than a decade, they have positioned themselves as pioneers in medical probiotics with pharmacy-first market entry, supported by local Healthcare Practitioners.

Differentiator

Problem solved

Functional benefit

Brands

  • Bactoblis: Probiotic product brand focused on oral microbiome health, marketed through the company's pharmacy channel.

Products and services

  • Bactoblis

Companies that use Bluestone Pharma

Customer profile

Segments3 records

Ideal customer profiles2 records

Bluestone Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Bluestone Pharma partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Bluestone Pharma competitors and assessment

Company assessment

Others

  • Chr. Hansen (now Novonesis): Global bioscience company and major probiotic strain supplier to many CPG and supplement brands. Comparable as the upstream strain/probiotic ingredient ecosystem participant that both supplies and competes with downstream brands like Bluestone.
  • Lallemand Health Solutions: Canadian probiotic ingredient manufacturer with documented oral and gut health strains. Comparable as an enabling ecosystem participant supplying probiotic raw materials and finished formulations in the same category Bluestone serves.

Emerging players

  • Hyperbiotics: US-based direct-to-consumer and pharmacy probiotic brand featuring a PRO-Dental oral probiotic SKU. Comparable as a smaller, brand-led probiotic company operating in the oral microbiome space with similar product formats (lozenges/sachets).

Direct peers

  • BLIS Technologies: New Zealand-based developer of BLIS K12 (Streptococcus salivarius K12), the foundational strain behind many oral probiotic products including Bactoblis. Closest direct competitor in the oral microbiome probiotic niche with overlapping strain technology and pharmacy-channel positioning.
  • BioGaia: Swedish probiotics specialist with BioGaia Prodentis (L. reuteri) targeting oral health. Comparable as a clinically-substantiated, HCP-endorsed oral probiotic brand sold through pharmacy channels globally.
  • BioGaia (Prodentis line): Note: see BioGaia above. BioGaia Prodentis is the most directly competing oral-health probiotic line with shared clinical, pharmacy, and HCP-led distribution model.
  • Winclove Probiotics: Dutch probiotic formulation company offering multi-strain oral microbiome products (e.g., Ecologic Oral). Comparable as a science-driven probiotics manufacturer selling finished formulations into healthcare/pharmacy channels.

Broad incumbents

  • Yakult: Japanese global probiotics giant with deep pharmacy and healthcare channel presence in 40+ countries. Comparable as a large, established probiotics brand that defines category norms and competes for HCP endorsement and consumer shelf space.
  • Culturelle (i-Health): Mass-market probiotic brand owned by i-Health (Ferrosan/Chr. Hansen lineage). Comparable as a pharmacy-distributed probiotic consumer brand with adjacent oral/dental extensions (Culturelle Dental) competing for the same shelf.
  • Danone (Probiotic Dairy & Supplements): Multinational food and dairy giant operating probiotic brands (Actimel, Activia) and adjacent supplement portfolios. Comparable as a deep-pocketed incumbent able to leverage scientific claims and global retail relationships to contest the oral probiotic niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Bluestone Pharma social profiles

Digital presence

Bluestone Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bluestone Pharma leadership team

Management profile

Number of profiles

Bluestone Pharma subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Bluestone Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bluestone Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bluestone Pharma

What does Bluestone Pharma do?

Bluestone Pharma develops and manufactures innovative probiotic formulations focused on the oral microbiome, marketed under the Bactoblis brand as lozenges and sachets. Products are sold through pharmacy channels across more than 30 international markets, with local Health Care Practitioners driving demand and prescription behavior.

Is Bluestone Pharma a public or private company?

Bluestone Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bluestone Pharma founded?

Bluestone Pharma was founded in 2014. It employs 1 to 10 people.

Where is Bluestone Pharma based?

Bluestone Pharma is headquartered in Baar, Switzerland, in the Europe region.

How does Bluestone Pharma make money?

One revenue line is on record: probiotic Product Sales.

Who are Bluestone Pharma's main competitors?

Others on record are Chr. Hansen (now Novonesis) and Lallemand Health Solutions. Hyperbiotics is listed as an emerging player. Direct peers are BLIS Technologies, BioGaia, BioGaia (Prodentis line) and Winclove Probiotics. Broad incumbents are Yakult, Culturelle (i-Health) and Danone (Probiotic Dairy & Supplements).

Does Bluestone Pharma have an API?

No public API is recorded for Bluestone Pharma.

What industry is Bluestone Pharma in?

Bluestone Pharma's product category is Probiotic Supplements. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of AFAKAJAH, Probiotic, Prebiotic & Gut-Health Foods Manufacturing (Fermented Functional Foods, Synbiotics). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales